文献速递主动脉疾病

EVAR 术后 1 个月早期 II 型内漏对中期结局的预后影响:两中心队列

Prognostic impact of early type II endoleak detected 1 month after endovascular aneurysm repair on midterm outcomes in a two-center cohort.
PubMed 文献 · J Vasc Surg · 2026-01-28

两中心 292 例退化性腹主动脉瘤 EVAR 患者按术后 1 个月影像分为 II 型内漏组(65 例,22.3%)与非内漏组;早期 II 型内漏与瘤囊扩张和內漏相关再干预独立相关,但与全因死亡无关。

要点

  • EVAR 术后 1 个月出现 II 型内漏者瘤囊扩张风险显著升高(HR 4.75)。
  • 早期 II 型内漏亦与内漏相关再干预独立相关(HR 3.08)。
  • 早期 II 型内漏未增加全因死亡,但仍需密切随访监测。

核心结论

  • EVAR 术后 1 个月检出的早期 II 型内漏与随访期间瘤囊扩张及内漏相关再干预显著相关,但不与全因死亡率升高相关,应密切监测。

研究设计与样本

  • 2009 年 1 月至 2024 年 12 月两中心共 444 例因主髂动脉瘤行 EVAR,最终纳入 292 例退化性大梭形腹主动脉瘤患者,按术后 1 个月影像分为 T2EL 组与非 T2EL 组。

主要发现

  • 1 个月时 65 例(22.3%)存在 T2EL、227 例无 T2EL,中位随访分别为 31.1 与 25.3 个月(P = .475)。
  • 瘤囊扩张在 T2EL 组 21 例(32.3%)、非 T2EL 组 16 例(7.0%)(P < .001)。
  • 内漏相关再干预在 T2EL 组 12 例(18.5%)、非 T2EL 组 9 例(4.0%)(P < .001)。
  • 全因死亡在 T2EL 组 19 例(29.2%)、非 T2EL 组 68 例(30.0%)(P = .282)。
  • 多变量分析示 1 个月 T2EL 独立关联瘤囊扩张(HR 4.75,95%CI 2.09-10.78,P < .001)与内漏相关再干预(HR 3.08,95%CI 1.10-8.61,P = .032)。

关键数值与推荐

  • 瘤囊扩张定义为直径增加≥5 mm。
  • 排除标准包括:主要适应证为髂动脉瘤、非退化性或破裂动脉瘤、无 1 个月影像或当时存在 I/III 型内漏。

临床怎么用

  • EVAR 术后 1 个月影像检出 II 型内漏者应纳入密切随访,重点监测瘤囊扩张及再干预需求。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Type II endoleak (T2EL) is the most common complication after endovascular aneurysm repair (EVAR). It is typically considered benign because of frequent spontaneous resolution. However, limited evidence exists on whether early T2EL, detected at 1 month post EVAR, can reliably predict adverse aortic outcomes during follow-up. METHODS: Between January 2009 and December 2024, 444 patients underwent EVAR for aortoiliac aneurysms at two centers. Patients whose main indication was iliac aneurysm, those with nondegenerative or ruptured aneurysms, and those without 1-month imaging or with type I/III endoleak at that time were excluded. The final cohort comprised 292 patients with a degenerative large fusiform abdominal aortic aneurysm. The patients were categorized into T2EL and non-T2EL groups based on 1-month imaging findings. The primary outcome was aneurysm sac expansion (≥5-mm increase); secondary outcomes were endoleak-related reintervention, open conversion, and all-cause mortality. RESULTS: Of the 292 patients, 65 (22.3%) had T2EL and 227 did not at 1 month post EVAR. The median follow-up durations were 31.1 and 25.3 months in the T2EL and non-T2EL groups, respectively (P = .475). Sac expansion occurred in 21 (32.3%) and 16 (7.0%) of the patients in the T2EL and non-T2EL groups, respectively (P < .001). Endoleak-related reintervention was performed in 12 (18.5%) patients with T2EL and 9 (4.0%) without T2EL (P < .001). All-cause mortality occurred in 19 patients (29.2%) with T2EL and 68 (30.0%) without T2EL (P = .282). In multivariable analysis, T2EL at 1 month was independently linked to sac expansion (hazard ratio, 4.75; 95% confidence interval, 2.09-10.78; P < .001) and endoleak-related reintervention (hazard ratio, 3.08; 95% confidence interval, 1.10-8.61; P = .032). CONCLUSIONS: Early T2EL identified at 1 month post EVAR was significantly related to sac expansion and endoleak-related reintervention during follow-up. Although it was not associated with increased all-cause mortality, its presence should be monitored closely. These findings supported the prognostic value of T2EL at 1 month in predicting adverse aortic outcomes after EVAR.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Kim H, Lee S, Hwang D, et al. Prognostic impact of early type II endoleak detected 1 month after endovascular aneurysm repair on midterm outcomes in a two-center cohort. J Vasc Surg. 2026. PMID: 41616880. doi:10.1016/j.jvs.2026.01.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。